PubMed Health⌕ Search

Biomedical subjects

T Sakuma

Publications and source records attributed to T Sakuma.

At least 271 records · Page 15Linked to original sources
PubMed1975

Congenital heart disease in forty years of age and over. Prevalence, relative incidence and clinical features.

The number of patients of C.H.D. over 40 years old was 40 (male 26, female 14) among 43285 (male 30320, female 12965). Its item: ASD 24, VSD 6, PDA 3, PS 3, ECD 2, Coarctation of the Aorta 1, Eisenmenger whose shunt site was unclear 1. The total prevalence rate was 0.92 per 1000 and female showed slightly higher rate than male (male 0.86 per 1000, female 1.08 per 1000). When it was compared with rheumatic valvular diseases, the ratio of both male and female was about 1/3. C.H.D. is assumed to decrease to about 1/3 or less between the period of school age and the middle age, but the prevalence rate over 60 years old was never lower than the overall prevalence investigated. C.H.D. in the middle and old aged should be kept in mind while examination.

Adult↗
PubMedDate not supplied

Design and synthesis of chemiluminescent substrates with high luminescent efficiency in an aqueous system: 5-tert-butyl-4,4-dimethyl-2,6,7-trioxabicyclo[3.2.0]heptanes bearing a 3-hydroxy-4-(1-iminoethyl)phenyl moiety at the 1-position.

A CIEEL-active dioxetane bearing a 4-acetyl-3-hydroxyphenyl moiety has very recently been found to emit light effectively, even in an aqueous system, albeit with a very slow CIEEL decay rate. As an attempt to improve the CIEEL decay rate of this type of dioxetane, three dioxetanes, in which a carbonyl in the 4-acetyl-3-hydroxyphenyl moiety was modified into an oxime, oxime O-methyl ether, or semicarbazone, were synthesized. These three dioxetanes decomposed to emit light far more rapidly than the parent 4-acetyl-3-hydroxyphenyl-substituted dioxetane. Among them, a dioxetane bearing a 3-hydroxy-4-(1-methoxyiminoethyl) phenyl, namely an oxime O-methyl ether derivative, gave high chemiluminescent efficiency. As for a semicarbazone derivative, decrease of the chemiluminescent yield was minimal, even in an aqueous system.

Acetonitriles↗
PubMedDate not supplied

Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa.

A nationwide, multicenter study of typical retinitis pigmentosa (RP) was carried out in collaboration with 18 hospitals throughout Japan to obtain current information for genetic counseling. We analyzed the genetic heterogeneity of RP based on the parental consanguinity of 434 probands registered during a 6-month period in 1990. A gradual decline in the frequency of consanguineous marriage was recognized among the normal parents of RP patients. The relative frequencies of inheritance patterns were estimated as: autosomal recessive, 25.2%; autosomal dominant, 16.9%; X-linked, 1.6%; and simplex, 56.3%. A comparison of these results with previous reports in Japan revealed a decline in the relative frequency of autosomal recessive cases and an increase in simplex cases. This suggests a decrease in the incidence of autosomal recessive retinitis pigmentosa in Japan, as well as the necessity for exhaustive investigations aimed at identifying inheritance patterns for RP patients seeking genetic counseling.

Adolescent↗
PubMedDate not supplied

Multicenter genetic study of retinitis pigmentosa in Japan: II. Prevalence of autosomal recessive retinitis pigmentosa.

Retinitis pigmentosa (RP) is a group of genetically heterogeneous diseases with autosomal recessive (AR), autosomal dominant, and X-linked modes of inheritance. Autosomal recessive retinitis pigmentosa (ARRP) is the most common form in Japan. A genetic analysis was done to determine the prevalence of ARRP indirectly, to provide an estimation of changing trends in the overall prevalence of RP. Data on the frequency of consanguinity and marriage year of normal parents of 59 ARRP patients were obtained from a nationwide multicenter survey of typical retinitis pigmentosa conducted in 1990. The gene frequency of ARRP was 0.01145 (Dahlberg's formula). In 1990, the number of young symptomatic ARRP patients decreased, while the number of patients aged 40 years and older increased. The total number of symptomatic ARRP patients in 1990 was nearly 21% higher than in 1970. Despite a dramatic decline in consanguinity in recent decades in Japan, the number of ARRP patients has increased. This increase is attributed to greater longevity and overall population growth. Our results suggest that the total number of RP patients has not decreased, and may even have increased.

Adolescent↗
PubMedDate not supplied

Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line.

Activation of the alternative pathway of homologous complement (C) was observed in a human lung adenocarcinoma cell line, CADO 43, after the cells had become apoptotic following treatment in vitro with vincristine and predonisolone. Deposition of C3b and C3bi on the serum-treated apoptotic cells was revealed by flow cytometry with anti-C3b and -C3bi-specific antibodies and immunoblotting with anti-C3 antibody immunoprecipitates extracted from solubilized fractions of serum-treated apoptotic cells. Two molecular mechanisms were found to be responsible for this post-apoptotic C-activation. Firstly, all C regulators, decay accelerating factor (DAF), membrane cofactor protein (MCP) and C3b/C4b receptor (CR1), were diminished on the cell surface concomitantly with the apoptotic process. Secondly, unidentified molecules which potentially activate homologous C and accept C3b/C3bi fragments became expressed on the cell surface during the apoptotic process. These findings may explain the mechanism whereby tumor cells are efficiently eliminated through chemotherapy.

Adenocarcinoma↗